Published in Neuropsychologia on October 26, 2010
Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (2014) 1.43
Mapping white matter integrity in elderly people with HIV. Hum Brain Mapp (2013) 1.05
White matter atrophy in Alzheimer's disease variants. Alzheimers Dement (2012) 0.91
Examining the value of lexical retrieval treatment in primary progressive aphasia: two positive cases. Brain Lang (2013) 0.88
Interrater reliability of the new criteria for behavioral variant frontotemporal dementia. Neurology (2013) 0.86
More than memory impairment in voltage-gated potassium channel complex encephalopathy. Eur J Neurol (2014) 0.86
Practice effects and amyloid deposition: preliminary data on a method for enriching samples in clinical trials. Alzheimer Dis Assoc Disord (2014) 0.85
Reliability measures of functional magnetic resonance imaging in a longitudinal evaluation of mild cognitive impairment. Neuroimage (2013) 0.84
The functional oculomotor network and saccadic cognitive control in healthy elders. Neuroimage (2014) 0.84
Cholinergic enhancement of functional networks in older adults with mild cognitive impairment. Ann Neurol (2013) 0.80
Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease. J Alzheimers Dis (2015) 0.79
Damage to left frontal regulatory circuits produces greater positive emotional reactivity in frontotemporal dementia. Cortex (2014) 0.77
Neuropsychological, behavioral, and anatomical evolution in right temporal variant frontotemporal dementia: a longitudinal and post-mortem single case analysis. Neurocase (2012) 0.76
The need for harmonisation and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: consensus document of the Joint Program for Neurodegenerative Diseases Working Group. Alzheimers Res Ther (2017) 0.75
Dysfunctional visual word form processing in progressive alexia. Brain (2013) 0.75
Lesion-symptom mapping of a complex figure copy task: A large-scale PCA study of the BCoS trial. Neuroimage Clin (2016) 0.75
MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes. Alzheimers Dement (Amst) (2016) 0.75
Identification of a rare coding variant in TREM2 in a Chinese individual with Alzheimer's disease. Neurocase (2017) 0.75
Is "Learning" Episodic Memory? Distinct Cognitive and Neuroanatomic Correlates of Immediate Recall During Learning Trials in Neurologically Normal Aging and Neurodegenerative Cohorts. Neuropsychologia (2017) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
An integrative theory of prefrontal cortex function. Annu Rev Neurosci (2001) 36.82
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52
Mechanisms of visual attention in the human cortex. Annu Rev Neurosci (2000) 8.50
Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol (2003) 3.66
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology (2007) 3.24
Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol (2008) 3.03
Evolution of neuronal changes in the course of Alzheimer's disease. J Neural Transm Suppl (1998) 2.83
The cognitive profile of posterior cortical atrophy. Neurology (2006) 2.64
Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen (2008) 2.00
Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. AJNR Am J Neuroradiol (2005) 1.97
Specific cognitive deficits in mild frontal variant frontotemporal dementia. Brain (1999) 1.95
Binding, spatial attention and perceptual awareness. Nat Rev Neurosci (2003) 1.68
Imaging correlates of posterior cortical atrophy. Neurobiol Aging (2006) 1.65
Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease. Neurology (2000) 1.63
Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol (1990) 1.62
Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry (1999) 1.55
Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology (2002) 1.49
The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET. J Neurol Neurosurg Psychiatry (2003) 1.48
Spatial disorientation in Alzheimer's disease: the remembrance of things passed. Neurology (2003) 1.48
Spatial cognition and the human navigation network in AD and MCI. Neurology (2007) 1.48
Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia. Arch Neurol (2003) 1.33
Focal right inferotemporal atrophy in AD with disproportionate visual constructive impairment. Neurology (2003) 1.25
Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.25
Patterns of frontal lobe atrophy in frontotemporal dementia: a volumetric MRI study. Dement Geriatr Cogn Disord (2006) 1.19
Comparison of neuropsychological functioning in Alzheimer's disease and frontotemporal dementia. J Int Neuropsychol Soc (1996) 1.12
Topographical disorientation in community-residing patients with Alzheimer's disease. Int J Geriatr Psychiatry (2004) 1.07
Frontotemporal dementia versus Alzheimer's disease: differential cognitive features. Neurology (1996) 1.05
Distinct cognitive profiles and rates of decline on the Mattis Dementia Rating Scale in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. J Int Neuropsychol Soc (2008) 1.03
Sulcal variability in the Alzheimer's brain: correlations with cognition. Neurology (1998) 1.03
Visual spatial cognition in neurodegenerative disease. Neurocase (2010) 1.03
Discriminant validity and neuroanatomical correlates of rule monitoring in frontotemporal dementia and Alzheimer's disease. Neuropsychologia (2007) 1.02
Visuoconstructional problems in dementia: contribution of executive systems functions. Neuropsychology (2000) 0.99
Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease. Neurobiol Aging (2006) 0.97
Gray matter correlates of set-shifting among neurodegenerative disease, mild cognitive impairment, and healthy older adults. J Int Neuropsychol Soc (2010) 0.94
Cognitive and behavioral differentiation of frontal lobe degeneration of the non-Alzheimer type and Alzheimer's disease. Dement Geriatr Cogn Disord (1998) 0.94
Frontotemporal dementia: patient characteristics, cognition, and behaviour. Int J Geriatr Psychiatry (2002) 0.93
Conflict monitoring in early frontotemporal dementia. Neurology (2009) 0.92
Left anterior subregion of orbitofrontal cortex volume reduction and impaired organizational strategies in obsessive-compulsive disorder. J Psychiatr Res (2004) 0.91
Driving abilities in frontotemporal dementia patients. Dement Geriatr Cogn Disord (2006) 0.90
Rule violation errors are associated with right lateral prefrontal cortex atrophy in neurodegenerative disease. J Int Neuropsychol Soc (2009) 0.87
Dementia of the frontal type: neuropsychological and [99Tc]-HM-PAO SPET features. J Geriatr Psychiatry Neurol (1995) 0.86
Attention, memory, and behavioral adjustment in children with frontal lobe epilepsy. Epilepsy Behav (2003) 0.85
[Car driving ability of patients with frontotemporal lobar degeneration and Alzheimer's disease]. Nervenarzt (2010) 0.84
A descriptive study on constructional impairment in frontotemporal dementia and Alzheimer's disease. Eur J Neurol (2008) 0.82
FDG-PET mapping the brain substrates of visuo-constructive processing in Alzheimer's disease. J Psychiatr Res (2009) 0.81
Higher cortical visual function. Curr Opin Ophthalmol (1998) 0.79
Misplacing objects in mild to moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial. J Neurol Neurosurg Psychiatry (2009) 0.78
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron (2011) 20.15
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Neurodegenerative diseases target large-scale human brain networks. Neuron (2009) 9.69
Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature (2005) 8.55
Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol (2004) 7.07
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med (2007) 6.80
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Frontotemporal dementia: clinicopathological correlations. Ann Neurol (2006) 5.14
Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol (2008) 4.15
Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain (2010) 3.84
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry (2010) 3.66
Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol (2003) 3.66
Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol (2003) 3.20
Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology (2005) 3.14
Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol (2005) 3.11
Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron (2012) 3.07
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol (2008) 3.03
Rapidly progressive dementia. Ann Neurol (2008) 3.00
Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol (2008) 2.96
Neuroanatomical correlates of behavioural disorders in dementia. Brain (2005) 2.92
Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology (2006) 2.79
Unravelling Boléro: progressive aphasia, transmodal creativity and the right posterior neocortex. Brain (2007) 2.75
Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain (2007) 2.72
Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol (2008) 2.71
Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol (2009) 2.68
Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol (2006) 2.62
Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord (2007) 2.43
Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol (2008) 2.41
Early frontotemporal dementia targets neurons unique to apes and humans. Ann Neurol (2006) 2.38
Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol (2005) 2.36
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol (2010) 2.30
Structural anatomy of empathy in neurodegenerative disease. Brain (2006) 2.28
Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol (2006) 2.27
Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol (2013) 2.26
Heritability of lobar brain volumes in twins supports genetic models of cerebral laterality and handedness. Proc Natl Acad Sci U S A (2002) 2.24
Connected speech production in three variants of primary progressive aphasia. Brain (2010) 2.19
The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol (2010) 2.19
Diagnosis of human prion disease. Proc Natl Acad Sci U S A (2005) 2.13
Sporadic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease. Arch Neurol (2003) 2.12
Psychometrically matched measures of global cognition, memory, and executive function for assessment of cognitive decline in older persons. Neuropsychology (2003) 2.11
White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain (2009) 2.08
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol (2007) 2.02
Functional connectivity tracks clinical deterioration in Alzheimer's disease. Neurobiol Aging (2011) 2.01
Case records of the Massachusetts General Hospital. Case 9-2015. A 31-year-old man with personality changes and progressive neurologic decline. N Engl J Med (2015) 1.97
Reliability and validity of the Delis-Kaplan Executive Function System: an update. J Int Neuropsychol Soc (2004) 1.96
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain (2013) 1.91
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol (2014) 1.90
Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology (2007) 1.88
Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia. J Biol Chem (2011) 1.88
Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. Cereb Cortex (2011) 1.87
Clinicopathological correlations in corticobasal degeneration. Ann Neurol (2011) 1.86
Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain (2010) 1.86
Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2013) 1.84
Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol Aging (2005) 1.83
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener (2013) 1.83
Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain (2008) 1.82
Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol (2007) 1.81
Progressive nonfluent aphasia and its characteristic motor speech deficits. Alzheimer Dis Assoc Disord (2007) 1.78
TDP-43 frontotemporal lobar degeneration and autoimmune disease. J Neurol Neurosurg Psychiatry (2013) 1.74
Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain (2007) 1.73
White matter damage in primary progressive aphasias: a diffusion tensor tractography study. Brain (2011) 1.73
Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs (2010) 1.72
C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. Neurology (2013) 1.70
Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology (2012) 1.69
Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol (2013) 1.68
Heightened emotional contagion in mild cognitive impairment and Alzheimer's disease is associated with temporal lobe degeneration. Proc Natl Acad Sci U S A (2013) 1.67
Cognitive and neuroimaging predictors of instrumental activities of daily living. J Int Neuropsychol Soc (2007) 1.66
Perioperative cognitive decline in the aging population. Mayo Clin Proc (2011) 1.66
Dissociable executive functions in behavioral variant frontotemporal and Alzheimer dementias. Neurology (2013) 1.65
Longitudinal changes in memory and executive functioning are associated with longitudinal change in instrumental activities of daily living in older adults. Clin Neuropsychol (2008) 1.62
Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet (2011) 1.60
Gene expression study on peripheral blood identifies progranulin mutations. Ann Neurol (2008) 1.59
Rapidly progressive dementia. Neurol Clin (2007) 1.58
TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions. Arch Neurol (2007) 1.57
Automated MRI-based classification of primary progressive aphasia variants. Neuroimage (2009) 1.55
Divergent social functioning in behavioral variant frontotemporal dementia and Alzheimer disease: reciprocal networks and neuronal evolution. Alzheimer Dis Assoc Disord (2007) 1.55
Double dissociation of social functioning in frontotemporal dementia. Neurology (2003) 1.54
Language networks in semantic dementia. Brain (2009) 1.50
Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc Natl Acad Sci U S A (2009) 1.49
Patterns of cognitive and emotional empathy in frontotemporal lobar degeneration. Cogn Behav Neurol (2005) 1.48